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Economic Evaluation of Health IT 
Abstract. Economic evaluation in health care supports decision makers in 
prioritizing interventions and maximizing the available limited resources for social 
benefits. Health Information Technology (health IT) constitutes a promising 
strategy to improve the quality and delivery of health care. However, to determine 
whether the appropriate health IT solution has been selected in a specific health 
context, its impact on the clinical and organizational process, on costs, on user 
satisfaction as well as on patient outcomes, a rigorous and multidimensional 
evaluation analysis is necessary. Starting from the principles of evaluation 
introduced since the mid-1980s within the Health Technology Assessment (HTA) 
guidelines, this contribution provides an overview of the main challenging issues 
related to the complex task of performing an economic evaluation of health IT. A 
set of necessary key principles to deliver a proper design and implementation of a 
multidimensional economic evaluation study is described, focusing in particular on 
the classification of costs and outcomes as well as on the type of economic 
analysis to be performed. A case study is eventually described to show how the 
key principles introduced are applied.  
Keywords. Health information technology, technology assessment, economic 
evaluation.  
1. Introduction  
The successful application and the consequent systematic adoption of a Health 
Information Technology (health IT) are broadly considered a promising strategy to 
improve the quality and delivery of health care. However, to determine whether the 
appropriate health IT solution has been selected in a specific health context, its impact 
on the clinical and organizational process, on costs, on user satisfaction as well as on 
patient outcomes, a rigorous and multidimensional evaluation analysis is necessary.  
Since the mid-1990s an increasing number of studies have addressed this issue, 
and some of them also include an economic evaluation with the aim of providing 
decision makers with a set of analyses that can support them in prioritizing 
interventions and maximizing the available limited resources for social benefits [1-2]. 
Being the “study of choice” [3], health economic evaluation is defined as the 
“comparative analysis of alternative courses of action in terms of both their costs and 
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consequences. Therefore, the basic task of any economic evaluation is to identify, 
measure, value and compare the costs and consequences of alternatives being 
considered” [4].  
Health IT has a supporting role both in the care process (diagnostic, 
treatment/therapy and nursing) and in the auxiliary process (for instance, appointing 
making, image archiving and documentation) [5]. Therefore, a causal relation [6] 
between the improvement of the efficacy and effectiveness of both care and auxiliary 
processes is usually very difficult to determine and measure. This makes the economic 
assessment of the health IT value – preferably in monetary terms – a challenging task, 
for a number of reasons e.g. the difficult identification of costs given, among other 
problems, the incremental development of many health IT solutions and their often 
locally adjusted implementation; the measurement of benefits that generally also 
depend on how systems are used, the organization and medical context in which they 
are embedded, and even on the national health system in place. 
As health IT does not directly alter the states of health or disease [7], compared to 
other types of technologies such as drugs or medical devices, benefits have to be 
measured in terms of changes in the health care and management processes, for 
instance improvements resulting from a better sharing of patients’ information, better 
resource allocation, or workload definition and deployment. This also implies that the 
economic evaluation has to combine or privilege different methods – qualitative and 
quantitative – that have to be coherently selected according to the objectives and 
perspective driving the assessment. Moreover, the difficulty in isolating the impact of 
health IT may be partially solved by distinguishing the main functionalities in: 1) 
capturing, storing, managing and sharing data; 2) informing and supporting clinical 
decision-making; 3) delivering expert professional and or consumer care remotely [8].  
Economic evaluation of health IT is still a research area. There are no common 
agreed and fixed standards that guide the performance of health economic analysis [9] 
considering the multiple dimensions on which health IT may have an impact. For these 
reasons systematic reviews generally reveal a limited number of economic evaluation 
compared to other types of analysis [10-11], poor use of analytical technique and 
documentation, partial identification of costs and benefits, or use of predictive analysis 
on assumptions based on limited empirical data. Moreover, although different 
evaluation frameworks and guidelines have been proposed (none of them specifically 
focused on economic evaluation of health IT), there is no uniform reporting of results, 
thus limiting the comparison across institutions.  
This contribution intends to contribute to the discussion on the methods and 
approaches supporting the assessment of health IT solutions by providing key features 
that support a scientifically sound economic evaluation. Section 2 provides a brief 
overview of the economic evaluation within the health technology assessment (HTA) 
framework as well as in a selected number of widely diffused health IT evaluation 
models. Section 3 summarizes some key principles that guide to a proper design and 
implementation of an economic evaluation of health IT, focusing in particular on the 
classification of costs and outcomes as well as on the main criteria used to choose the 
type of analysis. These principles are applied in a case study described in section 4.  
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2. The framework of the economic evaluation development  
Economic evaluation was the major focus of the first governmental national agencies 
that were constituted to develop Health Technology Assessment (HTA) round the mid 
1970s. The main concern was the rising expenditure for health care, the rapid change of 
health technology generally associated with the ageing of population and increased 
population health care service demand. The establishment of the US Office of 
Technology Assessment (OTA) – replaced by the Agency for Health Care Policy and 
Research which in turn became the Agency for Health Research and Quality (AHRQ) – 
clearly identified its scope as provider of analyses to support decision makers in 
“formulating policies to ensure that research-and–development funds are invested 
wisely” [12].  
The subsequent development of similar national agencies in Europe, even if 
generally motivated by rationalising health care expenditure and by cost containments, 
soon addressed issues more closely related to quality and safety of care as well as 
social and ethical implications [13]. This has led to the adoption of a more 
comprehensive approach to technology assessment that considers economic evaluation 
as part of a more complex framework of analysis that includes – at least at the level of 
HTA scope statements [14] – the technological, patient and organisational dimensions.2 
Moreover, other evaluation approaches developed within the Cochrane Collaboration 
and the evidence-based medicine (EBM) movement3 contributed to the consideration of 
economic evaluation as a specific phase of the assessment process, generally performed 
after safety, efficacy and effectiveness of interventions have been analysed [15].  
The application of HTA differs from country to country, being influenced by the 
national health care system in place, and by the aim and mandate of the agencies 
performing the assessment. This pertains also to the economic evaluation that 
depending on the national agency tends to privilege certain types of analysis (for 
instance cost-utility instead of cost-effectiveness) and/or prefers to consider certain 
types of cost and/or benefit [16]. Moreover, even if most HTAs have broadened the 
range of technology to include drugs, medical device, procedures and organisational 
and support system for care provision, the majority of analysis are generally focused on 
pharmaceutical products. This has the consequence that traditionally applied methods 
to verify safety and efficacy of drugs such as RCT (Randomized Clinical Trials) have 
been privileged making the evaluation of the impact of health IT limited to certain 
aspects, such as system performance or particular changes in clinical practices that may 
affect patient care [17, 18].4  
Despite differences and specificities, HTA has had the merit of providing a set of 
principles for the conduct of a sound evaluation defining the main steps and contents of 
the study design, providing guidance on types of economic analysis to be performed, 
on criteria and methods to be followed in the collections and analysis of data as well as 
in the reporting of evaluation results. 
However, the need to specifically address the evaluation of health IT has led to the 
development of further frameworks, differently connected with HTA, that are 
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conventionally classified as subjectivist approaches [17, 18]. These frameworks 
complement each other [19], as they each tend to privilege a specific perspective of the 
health IT evaluation, focusing on user behaviour and perception, or emphasising 
social/organizational relationships or software lifecycle. They are generally based on 
qualitative approaches that use among other methods interviews, questionnaires, or 
focus groups to perform their analysis (see reviews [20, 21] that use this classification 
of frameworks). Moreover, comprehensive and multi-dimensional frameworks have 
been developed to include the different aspects that influence health IT adoption and 
applying matrix and/or taxonomy to identify the main components to be taken into 
account in the evaluation.  
Worth mentioning is the Information System Success model proposed by DeLone 
and McLean [6, 22], which provides a framework of interconnected aspects that should 
be considered also when performing an economic evaluation. The model is based on a 
taxonomy of six interrelated dimensions that measure the system quality (e.g. system 
performance and use), information quality (e.g. accuracy, reliability, etc.), service 
quality (e.g. the overall support delivered by the service provider), system use (e.g. 
human acceptance or resistance toward the system), user satisfaction (e.g. positive 
experiences in using the system) and net benefit (e.g. the combination of individual and 
organizational impact). The first three dimensions are to be measured singularly or 
jointly to evaluate how they affect the two closely interrelated variables of system use 
and user satisfaction so to ascertain the net benefit, which in the DeLone and McLean 
previous version of the model [6] were described as the individual and organisational 
impact. Net benefit thus summarises the outcomes of this complex interaction 
providing a value – a positive or negative association in DeLone and McLean terms – 
that can be transformed into an economic evaluation.  
Further developments [23, 24] of the Information System Success model have 
given in more recent times a major focus on the organisational component and identify 
a more complex set of interactions among the dimensions identified by DeLone and 
McLean. The category of net benefits, common to these frameworks, helps in the 
identification of outcomes derived by the interaction of these dimensions and provides 
the basis for both qualitative and quantitative analyses on which to derive for instance 
cost reduction resulting from productivity and/or reduced time in performing specific 
tasks, error decline in terms of adverse events as well as impact on patient care and 
access to information. 
3. Principles of economic evaluation of health IT  
Guidelines on evaluation agree on the importance of the identification of a specific and 
clear research question that details the purpose of the analysis.5 The scope of the 
economic evaluation also defines the perspective of the analysis that has to match the 
need of the commissioning body that generally poses the study question. The scope and 
perspective of the research question determine the type of study design as well as the 
appropriate approach to analyse data collected during the evaluation framework. The 
key elements of the economic evaluation framework are shown in Figure 1 and 
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described in the following paragraphs. They are based on the criteria described in 
selected HTA guidelines containing a specific part on economic analysis [1, 25-27]. 
 
Figure 1. Principles of the economic evaluation of health IT. 
3.1. Study design  
Depending on the research question, the study design has to consider the key principles 
listed below and choose for each one the appropriate approach.6  
The perspective represents the point of view from which the study is conducted 
(individual, organizational, societal). Clearly establishing the perspective of the 
economic evaluation is particularly important for the identification of costs, resources 
and consequences to be examined. This also ensures comparability of different analyses. 
The perspective can be limited to the primary stakeholders of the health care system 
(e.g. physicians), or it can consider impact on the organization or even on the welfare 
system. In the latter case, a wider range of relevant costs and consequences are 
considered including those that are related to other public sector agencies, patients or 
their carers.  
The identification of the research method [28] is mainly based on the knowledge 
about the problem to be analysed. When the problem is not well defined the study is 
conducted using an exploratory research, for example using a case study to generate a 
hypothesis and find the relationships between the introduction of a new technology and 
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its effect on the context where it is deployed. In this approach data are collected from 
literature reviews, databases and/or from relevant stakeholders (e.g. physicians, 
patients) using techniques such as informal discussions, in-depth interviews, or focus 
groups. Conversely, an explanatory research is adopted when the investigation is 
conducted analysing the relation between the cause (e.g. technology to be adopted) and 
the effect (e.g. costs and outcomes) derived from the introduction of the health IT. This 
relationship is explored using two main research methods: experimentation (e.g. 
randomized clinical trial performed in a hospital), and statistical research (e.g. multiple 
regression techniques). A clear identification of the research method is helpful to 
determine the best research design and data collection method as well as the selection 
of the target population.  
The type of assessment indicates in which phase of the development lifecycle the 
health IT is analysed. Substantially, a technology can be evaluated throughout the 
whole development lifecycle using a formative approach, providing information on the 
system under development that may also lead to improvement or modifications. Once 
the system has been implemented, assessment of the effect/outcome is performed using 
a summative evaluation.  
The type of study determines whether the relationship between costs and outcomes 
deriving from the introduction of a new technology is analysed at one particular time 
during the system deployment (i.e. cross-sectional study) or repeatedly observed over 
time with continuous monitoring (i.e. longitudinal study). Type of study also includes 
the identification of inclusion and exclusion criteria of the target population.  
The identification of the comparator is one of the most significant activities of the 
economic evaluation framework. The new technology can be introduced as an 
improvement of existing, generally paper-based, routine care system (i.e. pre/post 
system implementation). In this case one or more relevant alternatives of the health IT 
under evaluation could be taken into account (same or different system comparator). 
These circumstances can involve either information systems that are classified in the 
same group of health IT or systems that share only a small set of functionalities. 
Moreover, it is also possible to evaluate a new process implemented by means of a 
health IT (i.e. with/without system comparison) to verify costs and benefits of the 
chosen solution.  
The appropriate time horizon of the evaluation specifies the period during which 
all the costs and outcomes are captured (short or long-term). It strictly depends on the 
research questions and can vary from a few days to several years capturing changes in 
the patient’s health status and/or impact of health IT over an expected time period. This 
implies the identification of outcomes and costs of alternative options measured in the 
specified period. It is also possible to explore multiple time horizons to verify the cost 
effectiveness of a health IT based on alternative scenarios.  
Once the scope has been identified and the study design determined, data 
collection and analysis can be performed. This implies on the one hand the choice of 
the most fitting type of economic analysis (to be identified within the full and partial 
analysis frameworks) and the selection of related type of resources (in terms of both 
costs and outcomes). On the other hand, it implies the identification of the types of data 
(e.g. qualitative and/or quantitative) as well as the source of data (e.g. systematic 
reviews, surveys, clinical information systems already deployed). The backwards arrow 
in Figure 1 sets forth the mutual influence between the data and the analysis domains: 
the decision towards the use of a given economic analysis somehow conditions the data 
retrieval; conversely, the deployment of a specific type of analysis might depend on the 
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purpose of the economic evaluation as well as on the availability of suitable data. It 
should also be noted that a combination of more than one type of analysis could be 
useful. The next sections describe in detail the classification of costs and outcomes and 
the different types of methods included within the framework of full and partial 
economic analysis. 
A structured report of results of the economic evaluation ensures eventually that 
the performed study is thoroughly presented and organized consistently to facilitate 
review and comparison by decision makers [29].7 The report has to be presented in a 
clear and transparent manner with enough information provided according to a 
consolidated schedule [30]. The Executive Summary and Conclusions should be 
written so that they can be understood by a non-technical reader, in order to enable the 
audience to critically evaluate the validity of the analysis. It is essential to explain and 
justify the choice of variables and methods, mention the reasons why certain data were 
excluded and last but not least describe in detail the organisational characteristics that 
may hinder or facilitate a health IT introduction or maintenance. However, it is likely 
that the results may not be (totally or in part) generalizable, as the key principles may 
differ significantly, e.g. between different jurisdictions or time periods.  
3.2. Classification of costs and outcomes  
The economic evaluation of health IT includes the identifications of costs to be 
quantified in monetary terms generally related to infrastructure (e.g. hardware, software, 
network), personnel (e.g. time spent for users’ training), facility (e.g. space necessary to 
store the technology) and other materials (e.g. consumable, paper) [e.g. 31, 32]. Table 1 
summarizes the different classes of costs as reported by referenced relevant literature.  
Table 1. Classification of costs. 
Description of costs categories (with 
references) Example of costs  
Tangible and intangible [e.g. 33] (level of 
measurability of the cost)  
Tangible: tablets  
Intangible: stress caused to a patient due to the health IT 
Direct and indirect [e.g. 34] (impact of the health 
IT)  
Direct: information system implementation  
Indirect: loss of productivity  
Health and non-health [e.g. 35] (cost related or 
not to the health sector)  
Health: outpatient visits  
Non-health: private travel costs  
One time and ongoing [e.g. 36] (cost is 
considered once or repeatedly)  
One time: local area network installed in the health 
facility  
Ongoing: software maintenance  
Average and marginal [e.g. 37] (cost is 
considered as a total amount or as a price per 
unit) 
Average: software implementation  
Marginal: personal computers  
Fixed and variable [e.g. 38] (cost remains 
constant or vary in proportion of the activities 
performed)  
Fixed: initial user training  
Variable: telephone bills  
Easily identifiable costs are generally related to the health IT implementation and 
maintenance as well as to the infrastructure supporting its deployment (e.g. PCs, 
network, printers). However, given that the introduction of a new technology impacts 
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on the core organizational and clinical processes, identification of indirect costs such as 
time spent for training and/or for modifying use of the technology (loss of productivity) 
are difficult to measure and therefore frequently overlooked and/or subjectively 
attributed to different classes [36].  
Similarly to costs, also outcomes can be classified as direct (e.g. investment 
reduction of personnel wages) and indirect (e.g. savings resulted from the decrease of 
adverse events) depending on whether the monetary savings are strictly related or 
induced by the introduction of the health IT. Moreover, outcomes can be related with 
the health of the patient (e.g. the reduction of medical errors) or not (e.g. time and 
money saved due to the reduction of patient transportation in a telemedicine program) 
[39]. However, the identification and classification of outcomes are even a more 
challenging task if compared with costs, as outputs are generally intangible and indirect 
measures related to the improvement of the patient’s health status as well as of the 
organizational process. This issue is also crucial considering that a parameter can 
describe more than one category of benefits implying an overestimation of outcomes. 
For instance adverse event prevention can be measured as an improvement of both 
quality of care and patient safety.8  
Many studies classify the same parameter either as a cost or an outcome of the 
health IT deployment. For instance, patient’s length of stay can be considered either as 
a cost [40, 41] or as a consequence of the intervention [42, 43] depending on the point 
of view of the analysis. It is therefore essential that authors give in the first place, to the 
greatest extent possible, a clear indication of the nature (costs or benefits) of the 
parameters used to perform the evaluation, in order to justify the results of the 
evaluation as well as allow its comparison with similar studies. 
Outcomes are not only a measure of the increase of revenues but also an 
assessment of the costs averted as a consequence of the introduction of the health IT. 
Their measurement implies a careful analysis as some costs may not be simply 
eliminated, but shifted to other hospital services or even to different components of the 
health care system [44]. This makes it also challenging to transform outcomes into a 
monetary value that is a necessary activity when the economic evaluation is performed 
using a Cost Benefit Analysis. For this reason analysts have often chosen other types of 
analysis that do not imply this conversion, such as Cost Analysis, or Cost Effectiveness 
Analysis [45].  
The difficulty in the identification and classification of outcomes has led different 
authors to adopt customized classifications considering, for instance, the impact of the 
Electronic Health Record [46, 47] that can result in outcomes about the patient flow 
(e.g. reduction of patient cycle time and increasing patient capacity), resource 
allocation (e.g. transcription, chart management and paper consumption), coding and 
billing (e.g. reduced billing errors), patient safety (e.g. decrease in infection rate), 
caring process (e.g. high quality of care) and staff compliance (e.g. reducing the 
redundancy of laboratory tests). Finally, the evaluation toolkit provided by the AHRQ 
[48] classifies the different measures that can be used to assess a health IT project in 
the following categories: patient safety (e.g. hospital complication rates), effectiveness 
(e.g. mortality), quality of care (e.g. documentation of key clinical data elements), 
efficiency (e.g. length of stay), and patient centeredness (e.g. patient knowledge). The 
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assessment of costs and outcomes included in the economic evaluation should take into 
account that the technology can lose its validity in a relatively short period of time. 
This is particularly true considering that health IT may become obsolete quite quickly, 
making it necessary to quantify costs to be invested to replace the technology after its 
use life as well as to consider the fast decline of prices (e.g. devaluation) of the 
technology that can be also caused by an increased value of production and a recovery 
of development charges. Moreover, an important aspect to be taken into account when 
performing an economic analysis is that the impact of a health IT often considers a 
broad period of time (for instance, Cost Benefit Analysis conducted on a 5-years 
period) that requires the correction of costs and outcomes for the effects of inflation to 
provide realistic resource costs. 
3.3. Type of economic analysis  
A health economic analysis aims to identify criteria to support decision makers in 
choosing between competitive alternatives the one which is most efficient and cost-
effective in an environment with limited resources [4, 10, 32, 33, 48]. This 
comprehensive analysis is achieved within the framework of a full economic evaluation 
when both costs and consequences of alternative interventions (e.g. intervention X 
versus comparator Y) are compared to assess their efficiency. A partial economic 
evaluation occurs instead when costs and outcomes are separately analysed (cost 
analysis/cost description; efficacy or effectiveness evaluation/outcome description) 
and/or alternative solutions are not considered (cost outcome description). Systematic 
reviews [34] indicate that the majority of economic evaluation studies generally 
perform cost analyses that focus on cost saving of two or more alternatives.  
Full economic evaluation represents a framework composed of different types of 
analysis, which are applied depending on the research questions, the viewpoint of the 
decision maker as well as data availability. Table 2 reports the most frequently adopted 
types of analysis giving a general description, the main objective as well as criteria that 
have to be fulfilled when choosing the appropriate method. What differentiates these 
analyses is the metric used as well as the number of parameters considered to evaluate 
the outcomes of the different interventions. The Cost Effectiveness Analysis (CEA) 
measures the health effects using a single outcome, such as the life years gained, while 
the Cost Utility Analysis (CUA) considers one or more outcomes aggregated in a 
global measure of health outcome, such as the QALY (Quality-Adjusted Life Years) or 
DALY (Disability Adjusted Life Years). CEA and CUA may use an incremental ratio – 
respectively, incremental cost-effectiveness ratio (ICER) and incremental cost-utility 
ratio (ICUR) – that allows comparison of the effectiveness of the intervention against 
an alternative solution given a fixed budget. When outcomes can be transformed in a 
monetary term a Cost Benefit Analysis (CBA) can be applied. However, even if this 
method can provide a useful indication for the right allocation of resources measuring 
whether gains overweight costs, its application has to face ethical issues as it means 
placing a value on the cost of human life.  
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Table 2. Types of full economic analysis.  
Methodo-
logy Description  Objective  Application Criteria  
Cost 
Effectiveness 
Analysis 
(CEA) 
Consequences of different 
health interventions are 
measured in natural units using 
a single outcome related to the 
objective of the program (e.g. 
life-years gained, adverse events 
avoided). 
To establish whether 
differences in expected 
costs between 
interventions can be 
justified in terms of 
changes in expected 
health effects.  
• Different interventions 
have to be compared 
using an uniform 
measurement of a single 
outcome  
• Outcomes cannot be 
expressed in monetary 
terms 
Cost Utility 
Analysis 
(CUA) 
As an extension of the CEA, it 
measures the strength of 
preference for a particular 
clinical outcome state. 
Outcomes are measured using 
QALY or DALY gained.  
To compare the value 
of interventions for 
different health 
problems, in order to 
facilitate the allocation 
of resources to 
maximize health gains.  
• Meaningful differences 
in the combination of 
the duration of life and 
health-related quality of 
life (HRQoL) between 
the interventions have to 
be demonstrated 
• Outcomes are not 
expressed in monetary 
terms 
Cost Benefit 
Analysis 
(CBA) 
It measures and values in 
monetary terms the benefits and 
costs of outcomes achieved 
from different programs or 
interventions.  
To address the 
efficiency in allocating 
resources between 
sectors  
• Outcomes have to be 
expressed in monetary 
terms  
 
Moreover, there are two additional types of analysis that are not reported in the 
Table 2 as they represent two specific forms of CEA: Cost Minimization Analysis 
(CMA) and Cost Consequence Analysis (CCA). In the CMA outcomes of alternative 
interventions have been proven to be identical and therefore only the least expensive 
option has to be determined. In the CCA multiple outcomes are analysed separately and 
compared with the relevant costs. This has the advantage of considering the full range 
of health and organisational effects of an intervention or when it is difficult or 
misleading to combine multiple outcomes from an intervention in a QALY for a CUA.  
4. Case study  
In this section we model a timely implementation of economic evaluation for health IT 
providing a case study based on the key principles described in section 3. 
Characteristics of the environment are: a mid-sized hospital (300 beds and 145 care 
professionals) that comprises Intensive Care Units (ICUs) hosting patients with 
comorbidities treated with multiple drugs. The hospital is already equipped with an 
Electronic Health Record (EHR) system that manages clinical and administrative 
patient data. The General Directorate intends to integrate the existing EHR with a 
Clinical Decision Support (CDS) module to overcome the current paper-based 
prescription procedures. The main scope is to support physicians in the choice of the 
appropriate medical treatment (drugs type and dosage), taking also into account the 
interaction with other drugs. Table 3 summarizes the key principles of the economic 
evaluation.  
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Table 3. Key principles of economic evaluation of the integration of a CDS module within an EHR system. 
Principle  Description  
Scope of the economic analysis  
Decision 
maker 
General Directorate of the hospital 
Emerging 
Needs 
Reduction of Adverse Drug Events (ADEs) caused by prescription errors that derive from:  
• interaction with other therapies (drug-drug interaction, DDI);  
• dosage and/or length of the therapy;  
• type of medicine prescribed. 
Research 
questions 
• Will the integration of the existing EHR with a CDS module improve the quality of 
care compared with the actual paper-based prescription procedure?  
• Is there particular evidence that the adoption of CDS modules reduce ADEs?  
• Will outcomes derived from the CDS balance the implementation and adoption cost?  
Study design  
Perspective Organizational: integration of the already deployed EHR system with a CDS module to 
improve the quality of treatment via the implementation of e-prescription procedures. 
Research 
methods 
A literature review is carried out to collect and analyse evidence on outcomes derived by 
the adoption of CDS module in other contexts (e.g. PubMed, Cochrane, AHRQ, York). 
Type of 
study 
Cross-sectional: the evaluation is conducted considering the number of ADEs occurred in 
a year. in a hospital with similar environmental characteristics.  
Time 
horizon 
The evaluation considers the costs and outcomes over a 5-years period.  
Comparator 
analysis 
Pre-post ADE alert system implementation: manual data entry of drug prescription 
procedures into EHR system versus EHR system integrated with a CDS module.  
Type of 
assessment 
Formative: the CDS module is assessed prior to its implementation.  
Data collection and analysis 
Type of 
economic 
analysis 
Incremental Cost Effectiveness Analysis  
Source of 
data 
Literature review; Open databank provided by the Ministry of Health; Budget proposal by 
vendors  
Type of 
data 
Quantitative  
Costs 
 
Productivity loss and hardware costs are not included considering that users are already 
confident with the use of health IT and the hospital is already equipped with PCs and 
printers.  
Costs of process changes have not been considered as CDS module effects only a limited 
part of the process. 
Outcome The number of ADEs that could be averted has been included as a unique indirect outcome  
 
The result of the Cost Effectiveness Analysis is reported in Table 4 highlighting 
costs to implement and maintain the CDS module as well as to train the physicians in 
its use. Costs have been measured based on the budget proposed by selected vendors 
and represented in US Dollars in order to pursue an as broad as possible visibility and 
data usability. The number of ADEs that could occur in a year have been captured from 
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an open data source released by the Italian Ministry of Health9 considering a health 
structure with the same environmental characteristics of the one under investigation; 
while the expected reduction of ADEs has been obtained from a literature review where 
different studies [32, 48-51] have reported that the introduction of a CDS module can 
reduce the number of adverse events by 40% to 80% each year. This wide range of 
percentage reduction makes it also necessary to perform a sensitivity analysis. Starting 
from the total costs and outcomes, the Incremental Cost Effectiveness Ratio (ICER) has 
subsequently been computed to determine the US dollars spent per ADE averted. 
 
Table 4. Results of the cost effectiveness analysis (in US Dollars). 
 0-year 1-year 2-year 3-year 4-year 5-year Total  
Costs (expressed in US Dollars) 
CDS implementation  500.000       500.000 
CDS maintenance   50.000 50.000 50.000 50.000 50.000 250.000 
User training (per user)  200 150      
User training (total)  
for 145 physicians  29.000 21.750     50.750 
Total costs  529.000 71.750 50.000 50.000 50.000 50.000 800.750 
Outcomes (based on initial 183 ADEs) 
# of ADEs (60% of ADEs 
averted)   110 110 110 110 110 550 
# of ADEs (40% of ADEs 
averted)  73 73 73 73 73 365 
# of ADEs (80% of ADEs 
averted)  146 146 146 146 146 725 
Cost-effectiveness analysis (Total expressed in US Dollar spent per ADE averted) 
ICER (60% of ADEs 
reduced)       1455.9  
ICER (40% of ADEs 
reduced)       2193.8 
ICER (80% of ADEs 
reduced)       1104.5 
 
Limitations of the study: The literature review to assess the percentage on ADEs 
reduced by the introduction of a CDS is based on heterogeneous studies considering 
specific functionalities implemented, population involved as well as the study design 
adopted. Moreover, ADEs are measured using different methodologies that often do 
not take into account non-intercepted ADEs (e.g. ADE occurred after the discharge). 
Another important aspect to be considered in this study is that ADEs are surrogate 
measures not necessarily directly related to changes in the patient-relevant medical 
outcomes. Moreover, the number of ADEs considered does not take into account the 
degree of severity of the adverse events.  
Note that the proposed simplified case study has to be considered as an educational 
example of the application of the principles of economic evaluation of health IT 
described in the previous section. When the evaluation analyses the replacement of a 
paper-based procedure, it is necessary to assess process changes that introduce a set of 
specific dimensions such as savings of ceasing old processes as well as costs of new 
processes, equipment costs, loss of production due to the introduction of a health IT.  
                                                 
9
 http://www.salute.gov.it/portale/documentazione/p6_2_8_1_1.jsp?id=6  
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5. Conclusions  
The rapidly changing technology as well as its adoption in increasing health-related 
environments (suffice it to think of m-Health applications) requires the economic 
evaluation to become an on-going assessment that includes a multidisciplinary team of 
experts to comprehensively consider the benefits of health IT introduction and use. 
The present contribution aimed to enrich the line of inquiry into economic 
evaluation approaches for the adoption and implementation of health IT, as a means to 
support decision makers in prioritizing interventions and maximizing the available 
limited resources for social benefits. The vast literature analysis conducted made clear 
that, though it is not possible to diverge from the principles of HTA, a sort of new 
interpretation (far from an adjustment) is necessary when applying the economic 
evaluation on health IT. This is a challenging task, as no consensus exists regarding the 
multiple dimensions to be considered when evaluating the indirect effects on patients’ 
health status as well as the impact on both health care and managerial processes. To 
this purpose, the authors’ main effort was to outline a set of guiding principles to 
conduct an appropriate analysis of costs and outcomes as well as to choose the proper 
type of economic evaluation. The case study has then applied the set of criteria 
emerging from the mentioned principles that can lead to a timely and consistent 
evaluation.  
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February 2016. 
Food for thought  
1. Which are pros and cons of a quantitative, objectivist research method? 
2. What are the advantages and issues related to the performance of a formative 
economic evaluation compared to a summative one? 
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3. What are the criteria to be considered when choosing the type of economic 
analysis? 
4. Think of some examples that describe the mutual relationship between the type of 
resources (costs and outcomes) and the availability of data to perform an economic 
analysis!  
5. When health IT replaces a paper-based procedure, which are the difficulties in the 
classification of costs and benefits? Make some examples. 
References 
[1] National Institute for Health and Care Excellence, Guide to the methods of technology appraisal, 2013, 
http://publications.nice.org.uk/pmg9, last access 11 February 2016.  
[2] M.S. Roberts, Economic aspects of evaluation, in: C.P. Friedman, J. Wyatt, Evaluation methods in 
medical informatics, New York, Springer, 2006. pp. 301-337. 
[3] A. Shiel, C. Donaldson, C. Mitton, G. Currie, Health economic evaluation, J. Epidemiology & 
Community Health 56 (2002), 85-88 
[4] M.F. Drummond, M.J. Sculpher, G.W Torrance, B.J. O’Brien, G.L. Stoddart, Methods for the 
economic evaluation of health care programmes, Oxford University Press, 2005.  
[5] R.P. van der Loo, E.M.S.J. van Gennip, A.R. Bakker. A. Hasnianb, F.F.H Rutten, Evaluation of 
automated information systems in health care: an approach to classifying evaluative studies, Computer 
Methods and Programs in Biomedicine 48 (1995), 45-52.  
[6] W.H. DeLone, E.R. McLean, Information Systems Success: The Quest for the Dependent Variable, 
Information Systems Research 3 (1992), 60-95. 
[7] C.S. Goodman, R. Ahn, Methodological approaches of health technology assessment, International 
Journal of Medical Informatics 56 (1999), 97-105.  
[8] A.D. Black, J. Car, C. Pagliari, C. Anandan, K. Cresswell, T. Bokun, B. McKinstry, R. Procter, A. 
Majeed, A.Sheikh, The impact of eHealth on the quality and safety of health care: a systematic 
overview, PLoS medicine 8(1) (2011), e1000387. 
[9] J. Hjelmgren, F. Berggren, F. Andersson, Health Economic Guidelines – Similarities, Differences and 
some Implications, Value in Health 4 (2001), 225-250. 
[10] E.L. Eisenstein, D.B.A. Maqui Ortiz, K.J. Anstrom, et al., Assessing the quality of medical information 
technology economic evaluation: rooms for improvements, in: AMIA 2006 Symposium Proceedings, 
pp. 234-8.  
[11] T. Reardon, Research findings and strategies for assessing telemedicine costs, Telemedicine Journal & 
e-Health 11 (2005), 348-369.  
[12] Office of Technology Assessment. Development of medical technology: opportunity for assessment: 
U.S. Government Printing Office, Washington DC, 1976.  
[13] D. Banta, The development of health technology assessment, Health Policy 63 (2003), 121-132. 
[14] E. Draborg, D. Gyrd-Hansen, P.B. Poulsen, M. Horder, International comparison of the definition and 
the practical application of health technology assessment, International Journal of Technology 
Assessment in Health Care 21 (2005), 89-95.  
[15] R. Busse, J. Orvain, M. Velasco, M. Perleth, M. Drummond, F. Gürtner, T. Jørgensen, A. Jovell, J. 
Malone, A. Rüther, C. Wild, Best practice in undertaking and reporting health technology assessments, 
International Journal of Technology Assessment in Health Care 18 (2002), 361-422. 
[16] J.M. Graf von der Schulenburg, C. Hoffmann, Review of European guidelines for economic evaluation 
of medical technologies and pharmaceuticals, HEPAC Health Economics in Prevention and Care 1 
(2000), 2-8.  
[17] B. Kaplan, Evaluating informatics applications - some alternative approaches: theory, social 
interactionism, and call for methodological pluralism, International Journal of Medical Informatics 64 
(2001), 39–56. 
[18] J.R. Moehr, Evaluation: salvation or nemesis of medical informatics? Computers in Biology and 
Medicine 32 (2002), 113-125. 
[19] M.M. Yosof, J.P. Paul, L.K. Stergioulas, Towards a framework for health information evaluation, in: 
Proceedings of 39th Hawaii International Conference on System sciences, Hawaii, IEEE 2006.  
[20] M.M. Yosof, A. Papazafeiropoulou, J.P. Paul, L.K. Stergioulas, Investigating evaluation frameworks 
for health information systems, International Journal of Medical Informatics 77 (2008), 377-385. 
D. Luzi et al. / Economic Evaluation of Health IT178
[21] L.M. Currie, Evaluation frameworks for nursing informatics, International Journal of Medical 
Informatics 74 (2005), 908-916. 
[22] W.H. Delone, E.R. McLean. The DeLone and McLean model of information systems success: a ten-
year update, Journal of Management Information Systems 19 (2003), 9-30. 
[23] M.S. Scott Morton, The Corporation of the 1990s, Oxford University Press, New York, 1991. 
[24] M.M. Yusof, J. Kuljis, A. Papazafeiropoulou, L.K. Stergioulas, An evaluation framework for Health 
Information Systems: human, organization and technology-fit factors (HOT-fit), International Journal 
of Medical Informatics 77 (2008), 386-398. 
[25] F.B. Kristensen, H. Sigmund (eds.), Health Technology Assessment Handbook, Danish Centre for 
Health Technology Assessment, National Board of Health, 2007, 
[26] Health Information and Quality Authority, Guidelines for the Economic evaluation of Health 
Technologies in Ireland, 2014. 
[27] Canadian Agency for Drugs and Technologies in Health, Guidelines for the Economic Evaluation of 
Health Technologies, Canada 3rd Edition, 2006.  
[28] E. Ammenwerth, N. de Keizer, Trends in Evaluation Research 1982-2002, Methods of Information in 
Medicine 44 (2005), 44-56. 
[29] EUnetHTA Joint Action 2. HTA Core Model v.2; 2013. http://www.corehta.info/BrowseModel.aspx, 
last access 11 February 2016. 
[30] J. Talmon, E. Ammenwerth, J. Brender, N. de Keizer, P. Nykänen, M. Rigby, STARE-HI - Statement 
on reporting of evaluation studies in Health Informatics, International Journal of Medical Informatics 
78 (2009), 1-9.  
[31] S.P. Slight, Q. Casey, A.J. Avery, DW Bates, A. Sheikh, A qualitative study identifying the cost 
categories associated with electronic health record implementation in the UK, Journal of the American 
Medical Informatics Association 21 (2014), e226-e231. 
[32] K. Li, S. Naganawa, K. Wang, P. Li, K. Kato, X. Li, J. Zhang, K. Yamauchi, Study of the cost-benefit 
analysis of electronic medical record systems in general hospital in China, Journal of Medical Systems 
36 (2012), 3283-3291. 
[33] S.J. Constantinos, A framework for the ex-ante evaluation of ERP software, European Journal of 
Information Systems 10 (2001), 204-215. 
[34] D. O’Reilly, J.E. Tarride, R. Goerre, C. Lokker, K.A. McKibbon, The economics of health information 
technology in medication management: a systematic review of economic evaluations, JAMIA 19 
(2012), 423-438. 
[35] T.S. Bergmo, Can economic evaluation in telemedicine be trusted? A systematic review of the 
literature, Cost Eff Resour Alloc 7 (2009): 18.  
[36] J. Bassi, F Lau, Measuring value for money: a scoping review on economic evaluation of health 
information systems, JAMIA 20 (2013), 792-801. 
[37] J. Polisena, D. Coyle, K. Coyle, S. McGill, Home telehealth for chronic disease management: a 
systematic review and an analysis of economic evaluations, International Journal of Technology 
Assessment in Health Care 25 (2009), 339-349.  
[38] M. Dávalos, M.T. French, A.E. Burdick, C. Scott, E. Simmons, Economic evaluation of telemedicine: 
review of the literature and research guidelines for benefit-cost analysis, Telemedicine and e-Health 15 
(2009), 933-948.  
[39] H. Mistry, Systematic review of studies of the cost-effectiveness of telemedicine and telecare. Changes 
in the economic evidence over twenty years, Journal of Telemedicine and Telecare 18 (2012), 1-6. 
[40] D.J. Chisolm, A.S. McAlearney, S. Veneris, D. Fisher, M. Holtzlander, K.S. McCoy, The role of 
computerized order sets in pediatric inpatient asthma treatment, Pediatr Allergy Immunol 17 (2006), 
199-206. 
[41] W.M. Tierney, M.E. Miller, J.M. Overhage, Physician inpatient order writing on microcomputer 
workstations: Effects on resource utilization, JAMA 269 (1993), 379-383. 
[42] H.S. Mekhjian, R.R. Kumar, L. Kuehn, T.D. Bentley, P. Teater, A. Thomas, B. Payne, A. Ahmad, 
Immediate benefits realized following implementation of physician order entry at an academic medical 
center, JAMIA 9 (2002), 529-539. 
[43] R.S. Evans, S.L. Pestotnik, D.C. Classen, A computer-assisted management program for antibiotics 
and other antiinfective agents, N Engl J Med 338 (1998), 232-238. 
[44] P.R. Orszag, Evidence on the costs and benefits of health information technology, Testimony before 
Congress 24 (2008). 
[45] S.J. Wang, B. Middleton, L.A. Prosser, C.G. Bardon, C.D. Spurr, P.J. Carchidi, A.F. Kittler, R.C. 
Goldszer, D.G. Fairchild, A.J. Sussman, G.J. Kuperman, D.W. Bates, A cost-benefit analysis of 
electronic medical records in primary care, The American Journal of Medicine 114 (2003), 397-403. 
D. Luzi et al. / Economic Evaluation of Health IT 179
[46] P. Tse, Systematic review: the return on investment of EHR implementation and associated key factors 
leading to positive return-on-investment, PhD Thesis, The University of Hong Kong (Pokfulam, Hong 
Kong), 2013. 
[47] C. Byrne, L.M. Mercincavage, E.C. Pan, A.G. Vincent, D.S. Johnston, B. Middleton, The value from 
investments in health information technology at the US Department of Veterans Affairs, Health Affairs 
29 (2010), 629-638.  
[48] AHRQ (Agency for Healthcare Research and Quality), Health Information Technology Evaluation 
Toolkit, 2009, https://healthit.ahrq.gov/sites/default/files/docs/page/health-information-technology-
evaluation-toolkit-2009-update.pdf, last access 11 February 2016.  
[49] R.C. Wu, A. Laporte, W.J. Ungar, Cost-effectiveness of an electronic medication ordering and 
administration system in reducing adverse drug events, Journal of Evaluation in Clinical Practice 13 
(2007), 440-448. 
[50] T. Bertsche, J. Pfaff, P. Schiller, J. Kaltschmidt, M.G. Pruszydlo, W. Stremmel, I. Walter-Sack, W.E. 
Haefeli, J. Encke, Prevention of adverse drug reactions in intensive care patients by personal 
intervention based on an electronic clinical decision support system, Intensive Care Medicine 36 
(2010), 665-672. 
[51] S.H. Forrester, Z. Hepp, J.A. Roth, H.S. Wirtz, E.B. Devine, Cost-effectiveness of a computerized 
provider order entry system in improving medication safety ambulatory care, Value in Health 17 
(2014), 340-349. 
D. Luzi et al. / Economic Evaluation of Health IT180
